The safety of isotretinoin treatment in patients with bone fractures

scholarly article published February 2019

The safety of isotretinoin treatment in patients with bone fractures is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5114/ADA.2019.82822
P932PMC publication ID6409881
P698PubMed publication ID30858774

P50authorLigia Brzezińska-WcisłoQ57032478
Beata Bergler-CzopQ59163323
Bartosz MiziołekQ91351805
P2093author name stringAnna Stańkowska
P2860cites workBone remodelling at a glanceQ57534055
Excessive Dietary Intake of Vitamin A Is Associated with Reduced Bone Mineral Density and Increased Risk for Hip FractureQ59806766
Serum calcium concentrations during treatment with isotretinoinQ68727981
13-cis-retinoic acid and bone densityQ70825387
Vitamin A antagonizes the action of vitamin D in ratsQ73208667
Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect levelQ73396246
Oral Isotretinoin Therapy in Severe Acne Induces Transient Suppression of Biochemical Markers of Bone Turnover and Calcium HomeostasisQ74833072
Bone densities in patients receiving isotretinoin for cystic acneQ78155140
Oral treatment with retinoic acid decreases bone mass in ratsQ79549601
The effects of isotretinoin treatment on bone mineral density in patients with nodulocystic acneQ80146773
Hypercalcemia caused by iatrogenic hypervitaminosis AQ81236373
THERAPEUTIC HOTLINE: Does isotretinoin have effect on vitamin D physiology and bone metabolism in acne patients?Q83630142
Isotretinoin effect on alveolar repair after exodontia--a study in ratsQ84593259
The effects of isotretinoin on wisdom tooth extractionQ84974417
Does Systemic Isotretinoin Inhibit Healing in a Porcine Wound Model?Q85316564
Isotretinoin effect on the repair of bone defects - a study in rat calvariaQ95476679
Is vitamin A consumption a risk factor for osteoporotic fracture?Q28250147
Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuationQ28315419
Hypervitaminosis A. A cause of hypercalcemia.Q28367971
Surgical Outcome in Patients Taking Concomitant or Recent Intake of Oral Isotretinoin: A Multicentric Study-ISO-AIMS StudyQ28828640
Bilateral nasal bone osteophytosis associated with short-term oral isotretinoin therapy for cystic acne vulgarisQ34251195
Vitamin A antagonizes calcium response to vitamin D in man.Q34518106
Serum retinol levels and the risk of fractureQ34530688
Vitamin a is a negative regulator of osteoblast mineralizationQ35067782
Vitamin A intake, serum vitamin D and bone mineral density: analysis of the Korea National Health and Nutrition Examination Survey (KNHANES, 2008-2011)Q35227871
Low-dose combined oral contraceptive use is associated with lower bone mineral content variation in adolescents over a 1-year periodQ35635526
Osteoblasts and osteoclasts in bone remodeling and inflammationQ36230480
Premature Epiphyseal Closure of the Lower Extremities Contributing to Short Stature after cis-Retinoic Acid Therapy in Medulloblastoma: A Case ReportQ36551444
Dual energy X-ray absorptiometry: Pitfalls in measurement and interpretation of bone mineral densityQ36930680
Pro-inflammatory cytokines in patients with various kinds of acne treated with isotretinoinQ37634325
The distribution of retinaldehyde dehydrogenase-2 in rat and human orodental tissuesQ38459053
Is It Safe to Operate on Patients Taking Isotretinoin?Q38674447
Aging - What Do We Know?Q39311876
The Negative Impact of Selective Activation of Retinoic Acid Receptors on Bone Metabolism and Bone Mechanical Properties in RatsQ39391241
High dietary intake of retinol leads to bone marrow hypoxia and diaphyseal endosteal mineralization in ratsQ39638116
Genetic and pharmacological inhibition of retinoic acid receptor γ function promotes endochondral bone formation.Q39668321
Retinoids inhibit differentiation of hematopoietic osteoclast progenitorsQ39834688
Retinoid-induced bone thinning is caused by subperiosteal osteoclast activity in adult rodentsQ40444590
RARγ is a negative regulator of osteoclastogenesisQ41175656
Hypercalcemia associated with oral isotretinoin in the treatment of severe acneQ42244205
Hypercalcemia: a dose-limiting toxicity associated with 13-cis-retinoic acid.Q42286167
Hypercalcaemia caused by all-trans retinoic acid (ATRA) treatment in a case of acute promyelocytic leukaemia was manageable after decreasing the ATRA dose to 27 mg/m2/dayQ42567054
What is the cumulative effect of long-term, low-dose isotretinoin on the development of DISH?Q43548639
Vitamin A intake and hip fractures among postmenopausal womenQ43832026
Type I collagen N-telopeptide variation in adolescents receiving oral isotretinoin for severe acneQ43873400
Retinol intake and bone mineral density in the elderly: the Rancho Bernardo StudyQ44089750
Serum Retinol Levels and Fracture RiskQ44433348
A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral densityQ45013291
Hypercalcaemia from non-prescription vitamin A.Q45117079
Effect of a single course of isotretinoin therapy on bone mineral density in adolescent patients with severe, recalcitrant, nodular acneQ45137387
Effects of isotretinoin on bone mineralization during routine therapy with isotretinoin for acne vulgarisQ46293444
Complications associated with isotretinoin use after rhinoplastyQ46415652
Hypercalcemia associated with all-trans retinoic acid therapy for microgranular type acute promyelocytic leukemiaQ46469493
Hypercalcemia due to an interaction of all-trans retinoic acid (ATRA) and itraconazole therapy for acute promyelocytic leukemia successfully treated with zoledronic acidQ46515800
Isotretinoin does have an adverse effect on bone mineral density.Q46555472
Bone mineral density and bone turnover markers in patients receiving a single course of isotretinoin for nodulocystic acneQ46598204
Retinoic acid receptor signalling directly regulates osteoblast and adipocyte differentiation from mesenchymal progenitor cells.Q50212889
Vitamin D Deficiency After Oral Retinoid Therapy for IchthyosisQ53526775
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectbone fractureQ68833
dermatologyQ171171
isotretinoinQ287029
bone healingQ1777289
retinoids [extracellular region]Q50266507
P304page(s)18-24
P577publication date2019-02-01
P1433published inPostępy Dermatologii i AlergologiiQ22965552
P1476titleThe safety of isotretinoin treatment in patients with bone fractures
P478volume36